2019 to 2020 saw 16.8 percent increase in U.S. death rate
Dec 22, 2021
The two leading causes of death continued to be heart disease and cancer, with COVID-19 the third leading cause of death in 2020.
COVID-19 vaccine does not increase CV event risk in those with existing disease
Jun 24, 2022
The findings show the safety of the BNT162b2 or CoronaVac vaccines in patients with cardiovascular disease.
Adenoviral-based COVID-19 vaccines may up short-term CV risk
Aug 23, 2022
An increased incidence of myocardial infarction and pulmonary embolism were seen in the second week after first dose of Oxford-AstraZeneca vaccine.
COVID-19 falls from America’s No. 1 killer to No. 7 by June
Jul 01, 2021
COVID-19 deaths have fallen sharply as vaccination rates have surged in recent months.
More medical lab tests will soon face federal scrutiny, FDA says
Apr 29, 2024
Laboratory tests used by millions of Americans are soon to be classified as medical devices, and as such be regulated by the US Food and Drug Administration, the agency announced Monday.
Risks for diabetes, CVD up in acute, postacute COVID-19 phases
Jul 20, 2022
However, from 13 to 52 weeks after COVID-19, no increase was seen for diabetes mellitus or cardiovascular disease.
Hypertension linked to hospitalization for omicron in vaccinated persons
Aug 09, 2022
The findings were seen among individuals who received at least three mRNA vaccine doses and in whom COVID-19 subsequently was diagnosed during omicron surge.
Prior statin use linked to reduced risk for death in COVID-19
Jul 21, 2021
The risk for death was significantly reduced with prior statin and/or antihypertensive use among those with a history of cardiovascular and/or hypertension.
Monoclonal antibody therapy may cut COVID-19 hospitalizations
Aug 31, 2021
Lower hospitalization rates were seen at 14, 21 and 28 days for high-risk patients with mild-to-moderate COVID-19 who received casirivimab-imdevimab.
COVID-19 vaccine priority populations vary by state, city: reports
By
Kimberly Bonvissuto
Dec 11, 2020
With the Food and Drug Administration’s vaccine advisory board recommending approval of the Pfizer-BioNTech COVID-19 vaccine for emergency use authorization on Thursday, two data analyses outline which...